Semax and Selank: Russia's Cognitive and Anxiolytic Peptides Explained

Semax and Selank are two peptides developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. They are approved pharmaceuticals in Russia and Ukraine — not research chemicals in those markets, but actual prescription drugs with clinical evidence. In the West, they occupy the regulatory gray zone.

They have distinct mechanisms and distinct applications, but they share an unusually clean safety profile compared to other cognitive and anxiolytic compounds. Understanding how they differ determines which one fits your goal.

Semax: The ACTH Analog

Semax is a synthetic heptapeptide derived from the sequence of ACTH (adrenocorticotropic hormone). It consists of the 4-10 fragment of ACTH with an added proline-glycine-proline (PGP) sequence that extends its stability and modifies its receptor profile.

Primary mechanisms:

• BDNF upregulation — Semax produces a rapid, significant increase in brain-derived neurotrophic factor (BDNF). This is its most studied and clinically relevant effect. BDNF drives neuroplasticity, synaptogenesis, and neuronal survival. The Russian clinical data shows measurable BDNF increases within 24 hours of administration.
• Dopaminergic and serotonergic modulation — Semax increases dopamine and serotonin turnover in the prefrontal cortex and hippocampus, which corresponds to its documented improvements in attention, focus, and working memory.
• Anti-ischemic / neuroprotective — In Russian clinical practice, Semax is primarily used for stroke recovery, TBI, and optic nerve disease. It reduces ischemic damage by upregulating neurotrophic factors and anti-apoptotic gene expression.

Clinical applications (Russia/Ukraine approved):
Stroke rehabilitation, TBI recovery, optic nerve atrophy, ADHD, memory impairment

Biohacking application:
Cognitive enhancement, focus, learning and memory consolidation, recovery from cognitive overload or brain fog

Dosing:
200–600mcg intranasally (drops or spray), 1–2 times daily
Cycle: 10–14 days on, 7–10 days off
Available as 1% solution (1mg/mL) from Russian and Ukrainian pharmacies or as lyophilized powder for reconstitution

Selank: The Tuftsin Analog

Selank is a synthetic hexapeptide based on tuftsin, an endogenous tetrapeptide derived from immunoglobulin G. Tuftsin has known immunomodulatory and anxiolytic properties. Selank adds three additional amino acids (Gly-Pro-Pro) that stabilize it and modify its activity profile.

Primary mechanisms:

• GABA-A modulation — Selank produces anxiolytic effects via GABA-A receptor potentiation, similar to but pharmacologically distinct from benzodiazepines. It produces anxiolysis without sedation, tolerance, or dependency — the key advantages over benzos.
• Enkephalin breakdown inhibition — Selank inhibits the enzymes that degrade enkephalins (endogenous opioid peptides), increasing their synaptic availability. Enkephalins modulate mood, stress response, and pain.
• BDNF upregulation — Like Semax, Selank increases BDNF, though this is a secondary effect rather than its primary mechanism.
• Immune modulation — As a tuftsin derivative, Selank has documented immunomodulatory effects, including IL-6 and interferon production. This is clinically relevant in the context of anxiety-immune crosstalk.

Biohacking application:
Anxiety reduction, stress management, sleep quality improvement, social anxiety, cognitive performance under stress (Selank produces the paradoxical combination of relaxation and mental clarity)

Dosing:
250–500mcg intranasally, 1–2 times daily
Can be used as needed (pre-performance anxiety) or on a cycle
Unlike benzodiazepines, Selank does not produce tolerance — it can be used continuously, though cycles are still preferred

Key Differences

Feature	Semax	Selank
Primary effect	Cognitive enhancement, focus	Anxiolytic, stress reduction
Primary mechanism	BDNF, dopamine/serotonin	GABA-A, enkephalins
Energy profile	Mildly stimulating	Calming with clarity
Use case	Study, work, learning	Performance anxiety, stress
Cycle need	Yes — 10-14 days on/off	Optional — lower tolerance risk

Stacking

Semax and Selank are frequently stacked — Semax for cognitive upregulation, Selank for anxiolytic modulation. The combination produces heightened focus without the anxiety that some users experience with Semax alone at higher doses (particularly individuals sensitive to dopaminergic stimulation).

Selank is also a natural partner for performance-anxiety situations: public speaking, high-stakes presentations, examinations. 250–500mcg intranasal 30–45 minutes before the event produces measurable anxiety reduction without the cognitive blunting of benzodiazepines or the performance impairment of alcohol.

For the complete cognitive stack including Semax, Selank, Cerebrolysin, and methylene blue, see the Cognitive Enhancement Protocol.